British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders
Open accessThe DOI matches its Crossref record; 272 of the 272 references it cites were found in a registry or an index.
Abstract
Sleep disorders are common in the general population and even more so in clinical practice, yet are relatively poorly understood by doctors and other health care practitioners. These British Association for Psychopharmacology guidelines are designed to address this problem by providing an accessible up-to-date and evidence-based outline of the major issues, especially those relating to reliable diagnosis and appropriate treatment. A consensus meeting was held in London in May 2009. Those invited to attend included BAP members, representative clinicians with a strong interest in sleep disorders and recognized experts and advocates in the field, including a representative from mainland Europe and the USA. Presenters were asked to provide a review of the literature and identification of the standard of evidence in their area, with an emphasis on meta-analyses, systematic reviews and randomized controlled trials where available, plus updates on current clinical practice. Each presentation was followed by discussion, aimed to reach consensus where the evidence and/or clinical experience was considered adequate or otherwise to flag the area as a direction for future research. A draft of the proceedings was then circulated to all participants for comment. Key subsequent publications were added by the writer and speakers at draft stage. All comments were incorporated as far as possible in the final document, which represents the views of all participants although the authors take final responsibility for the document.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“there is a rationale for using CBT with both PI and IdI patients.”
In the citing paper
“This is especially true for trazodone that is very often used as a sleep-promoting drug [3, 39 -42].”
From Effects of Antidepressants on Sleep (2017) · cites this paper as [42]
In the citing paper
“International guidelines recommend cognitive behavioural interventions and medications as effective specific treatments for insomnia disorder, 11-14”
In the citing paper
“As a result, pharmacological treatment is now recommended only for the acute management of insomnia disorder 11-14”
In the citing paper
“Current treatment guidelines have conflicting recommendations, 11-14 and the findings from our study differ from those of a systematic review and network meta-analysis about hypnotics for insomnia in older adults, 37 which included 24 studies (5917 patients) and listed doxepin, zaleplon, and suvorexant among the best options.”
Citations
Cites
Arzneimittelforschung: Erstanwendung am Menschen in der Phase I
Miletzki, B., & Gleiter, C. H. (2005) · Bundesgesundheitsblatt Gesundheitsforsch.Gesundheitsschutz · doi:10.1007/s00103-005-1024-7 · Cited by 9,355
Hypothalamic regulation of sleep and circadian rhythms
Saper, C. B., Scammell, T. E., & Lu, J. (2005) · Nature · doi:10.1038/nature04284 · Cited by 2,804 · cited 2×
“In addition the newly discovered orexin system with cell bodies in the hypothalamus promotes wakefulness through regulating arousal ‘pathways’ (and inhibiting sedative ones) (Samuels and Szabadi, 2008; Saper et al., 2005).”
BackgroundEpidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?
Ford, D. E. (1989) · JAMA · doi:10.1001/jama.262.11.1479 · Cited by 2,440
Epidemiologic Study of Sleep Disturbances and Psychiatric Disorders: An Opportunity for Prevention?
Ford, D. E. (1989) · JAMA · doi:10.1001/jama.1989.03430110069030 · Cited by 2,252
Sleep disturbance and psychiatric disorders: A longitudinal epidemiological study of young Adults
Breslau, N., Roth, T., Rosenthal, L., & Andreski, P. (1996) · Biological Psychiatry · doi:10.1016/0006-3223(95)00188-3 · Cited by 1,831
The hyperarousal model of insomnia: A review of the concept and its evidence
Riemann, D., Spiegelhalder, K., Feige, B., Voderholzer, U., Berger, M., Perlis, M., & Nissen, C. (2010) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2009.04.002 · Cited by 1,789
Quantity and Quality of Sleep and Incidence of Type 2 Diabetes
Cappuccio, F. P., D'Elia, L., Strazzullo, P., & Miller, M. A. (2010) · Diabetes Care · doi:10.2337/dc09-1124 · Cited by 1,670
Prevalence of Sleep-disordered Breathing in Women
BIXLER, E. O., VGONTZAS, A. N., LIN, H.-M., TEN HAVE, T., REIN, J., VELA-BUENO, A., & KALES, A. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.163.3.9911064 · Cited by 1,598 · cited 1×
“This is due to a variety of reasons: climacteric symptoms such as hot flushes due to hormonal changes, psychiatric disorders and a rise in the incidence of sleep-disordered breathing (Bixler et al., 2001).”
BackgroundA marker for the end of adolescence
Roenneberg, T., Kuehnle, T., Pramstaller, P. P., Ricken, J., Havel, M., Guth, A., & Merrow, M. (2004) · Current Biology · doi:10.1016/j.cub.2004.11.039 · Cited by 1,585
Psychological and behavioral treatment of insomnia: update of the recent evidence (1998-2004)
Morin, C. M., Bootzin, R. R., Buysse, D. J., Edinger, J. D., Espie, C. A., & Lichstein, K. L. (2006) · Sleep · doi:10.1093/sleep/29.11.1398 · Cited by 1,345
Self-citation
Research works printed but not linked: 27
- 10.1177/026988110001400101 · DOI · Paper page
- Aurora RN, J Clin Sleep Med, 6, 85
- Balter MB, 1992, J Clin Psychiatry, 53, 34
- Benet LZ, Oie S. and Schwartz JB ( 1996) Design and optimization of dosage regimens: Pharmacokinetic data. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG (eds), Goodman and Gilman’s: The Pharmacological Basis of Therapeutics, 9th edn. New York: McGraw-Hill, pp. 1707-1792.
- Buscemi N., 2005, Evid Rep Technol Assess, 125, 1
- Cooper AJ, 1987, J Clin Psychiatry, 48, 209
- Gaillot J., 1982, Int Pharmacopsychiatry, 17, 76
- Herxheimer A., 2002, Cochrane Database Syst Rev, 2, CD001520
- ICD-10, 1992, The ICD-10 Classification of Mental and Behavioural Disorders - clinical descriptions and diagnostic guidelines
- Idzikowski C., 1988, Sleep, 7, 43
- Katz DA, 2002, J Fam Pract, 51, 229
- Kosky C., 2008, J Sleep Res, 17, 19
- Koytchev R., 1994, Arzneimittelforschung, 44, 121
- Léger D., 2010, Sleep Med Rev
- Mindell JA, 2006, Sleep, 29, 1263
- Montgomery P., 2003, Cochrane Database Syst Rev, 1, CD003161
- Morphy H, Dunn KM, Lewis M, Boardman HF and Croft PR, 2007, Sleep, 30, 274
- NIH, 1983, NIH Consensus Statement, 4, 1
- Nutt DJ, 2009, J Psychopharmacol
- Richelson E., 1994, J Clin Psychiatry, 55, 34
- Riemann D., Drugs, 69, 43
- Sansone RA, 2010, Psychiatry, 7, 13
- Shekelle PG, 1999, West J Med, 170, 348
- Shepertycky MR, 2005, Sleep, 28, 309
- Varkevisser M., 2005, Sleep, 28, 1588
- Zammit GK, 1999, Sleep, 22, S379
- Zimmermann T., 1998, Arzneimittelforschung, 48, 5
Cited by
Sateia, M. J., Buysse, D. J., Krystal, A. D., Neubauer, D. N., & Heald, J. L. (2017) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.6470 · Cited by 1,519
Self-citationNew perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation
Zisapel, N. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14116 · Cited by 860
Sleep disturbance and psychiatric disorders
Freeman, D., Sheaves, B., Waite, F., Harvey, A. G., & Harrison, P. J. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30136-x · Cited by 843
Morin, C. M., Drake, C. L., Harvey, A. G., Krystal, A. D., Manber, R., Riemann, D., & Spiegelhalder, K. (2015) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2015.26 · Cited by 746
Self-citationBaldwin, D. S., Anderson, I. M., Nutt, D. J., Allgulander, C., Bandelow, B., den Boer, J. A., Christmas, D. M., Davies, S., Fineberg, N., Lidbetter, N., et al. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114525674 · Cited by 676
“process the BAP has developed and periodically revised a series of consensus statements on the use of psychotropic drugs in patients with psychiatric and other disorders, with an emphasis on making concise and realistic recommendations based on a review of the evidence [IV] (Anderson et al., 2000, 2008; Barnes and Sch…”
BackgroundSelf-citation
Metadata
- Authors
- Wilson, S., Nutt, D., Alford, C., Argyropoulos, S., Baldwin, D., Bateson, A., Britton, T., Crowe, C., Dijk, D.-J., Espie, C., Gringras, P., Hajak, G., Idzikowski, C., Krystal, A., Nash, Jr., Selsick, H., Sharpley, A., & Wade, A.
- Affiliations
- University of Bristol (GB)
- Edmond Safra Chair in Neuropsychopharmacology, Imperial College London, UK
- University of the West of England (GB)
- King's College London (GB)
- Clinical Neuroscience Division, University of Southampton, UK
- University of Leeds (GB)
- King's College Hospital, London, UK
- Mater Private Hospital (AU)
- University of Surrey (GB)
- University of Glasgow Sleep Centre, Sackler Institute of Psychological Research, University of Glasgow, UK
- University of Regensburg (DE)
- Edinburgh Sleep Centre, SAAS, Edinburgh, UK
- Duke University (US)
- Betsi Cadwaladr University Health Board (GB)
- University College London Hospitals NHS Foundation Trust (GB)
- University Department of Psychiatry, Warneford Hospital, Oxford, UK
- CPS Clinical Research Centre, Glasgow, Scotland, UK
- Corresponding author
- Wilson, SJ
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2010-09-02
- Volume
- 24
- Issue
- 11
- Pages
- 1577-1601
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W2126710165
- Cited by
- 634
- References
- 271
- Citations by year
- 2026: 9 · 2025: 24 · 2024: 33 · 2023: 37 · 2022: 56 · 2021: 71 · 2020: 53 · 2019: 46 · 2018: 56 · 2017: 34 · 2016: 42 · 2015: 37 · 2014: 38 · 2013: 38 · 2012: 34
- FWCI
- 39.78
- Type
- journal article
- Language
- en
- Open access
- green
- eprints.uwe.ac.uk
- Licence
- cc-by
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Open Research (University of Surrey) (submittedVersion)
- UWE Research Repository (UWE Bristol) (submittedVersion, cc-by)
- University of Regensburg Publication Server (University of Regensburg) (submittedVersion)
- Surrey Research Insight Open Access (The University of Surrey) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
- Keywords
- insomnia, parasomnias, circadian rhythm disorders, sleep disorders, psychopharmacological treatment, evidence-based treatment, treatment guidelines
- MeSH terms
- Aged, Aged, 80 and over, Child, Female, Humans, Hypnotics and Sedatives, Sleep Initiation and Maintenance Disorders, Male, Middle Aged, Pregnancy, Sleep Wake Disorders, Substance Withdrawal Syndrome, Time Factors, Meta-Analysis as Topic, Cognitive Behavioral Therapy, Randomized Controlled Trials as Topic, Treatment Outcome, Neurotransmitter Agents, Evidence-Based Medicine, Chronobiology Disorders, Consensus
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. https://app.cochat.ai/papers/10.1177/0269881110379307
- The paper
- Wilson, S., Nutt, D., Alford, C., Argyropoulos, S., Baldwin, D., Bateson, A., Britton, T., Crowe, C., Dijk, D.-J., Espie, C., Gringras, P., Hajak, G., Idzikowski, C., Krystal, A., Nash, Jr., Selsick, H., Sharpley, A., & Wade, A. (2010). British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. Journal of Psychopharmacology. https://doi.org/10.1177/0269881110379307
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.